
Dabigatran Etexilate
Pradaxa 110 mg CapsuleStarting at
$235.99

Dabipla 110 mg Capsule is a prescription anticoagulant that contains 110 mg of dabigatran etexilate in each capsule. It belongs to the direct oral anticoagulant (DOAC) class, also called a blood thinner, and is used to help prevent and treat harmful blood clots.
Prescription required — you can upload it at checkout or later
| Pack Size | Qty | Price | Add to cart | Unit Price |
|---|---|---|---|---|
| 30 capsule/s | $78.99 | $2.63 | ||
| 60 capsule/s | $138.99 | $2.32 | ||
| 90 capsule/s | $181.99 | $2.02 |
Save more with our biggest pack
Free shipping on orders of $199 or more
Dabipla 110 mg Capsule is a prescription anticoagulant that contains 110 mg of dabigatran etexilate in each capsule. It belongs to the direct oral anticoagulant (DOAC) class, also called a blood thinner, and is used to help prevent and treat harmful blood clots. Dabipla 110 mg Capsule may be prescribed for conditions such as atrial fibrillation-related stroke prevention and treatment or prevention of deep vein thrombosis and pulmonary embolism, depending on the patient and doctor’s plan. This capsule is one specific strength made by Cipla, India, and it should be used exactly as directed.
How it works: Dabigatran etexilate is a prodrug that is converted in the body to dabigatran, which directly blocks thrombin, a key protein needed to form blood clots. In capsule form, Dabipla 110 mg Capsule delivers the medicine for regular oral use so it can help stop clots from forming or getting larger.
Dabipla 110 mg Capsule is a mid-to-higher strength capsule, so it is typically chosen for patients whose doctor wants a specific anticoagulation level and who are not using a lower dose. It is not a starter dose for everyone; the 110 mg strength may be selected based on kidney function, age, bleeding risk, and the reason for treatment. Because dabigatran begins working after it is absorbed, the capsule is not a fast-relief medicine and should be taken on schedule rather than as needed.
Each Dabipla 110 mg Capsule provides 110 mg of dabigatran etexilate. The doctor decides how often it should be taken, and in some patients it may be prescribed twice daily; the maximum daily amount depends on the reason for treatment, kidney function, age, and bleeding risk. Do not change the dose or stop taking Dabipla 110 mg Capsule without medical advice, because the safest schedule is individualized.
Do not change your dose or stop the medicine without speaking to your doctor.
Common side effects of Dabigatran Etexilate may include:
Get medical help right away if you notice:
Keep Dabipla 110 mg Capsule in its original strip/box at room temperature, dry, and away from moisture and heat.
Dabipla 110 mg Capsule is used to help prevent and treat blood clots. Doctors may prescribe it for stroke prevention in non-valvular atrial fibrillation or for DVT and PE, depending on the patient’s needs.
Swallow Dabipla 110 mg Capsule whole with water and do not open, crush, or chew it. It can be taken with or without food, but you should take it at the exact times your doctor prescribes.
Dabipla 110 mg Capsule is a mid-to-higher strength capsule and is not the same as a lower starting dose used for some patients. Your doctor chooses this strength based on factors like kidney function, bleeding risk, age, and the condition being treated.
Avoid NSAID pain relievers and tell your doctor about any other blood thinners or interacting medicines. Also, do not stop Dabipla 110 mg Capsule suddenly unless your prescriber tells you to, because that can increase clot risk.
No written reviews yet.
Same as Dabigatran Etexilate